Sandoz Files Biosimilar Humira & Remicade In EU; 13 Products Now Under Evaluation By CHMP

 
• By Ian Schofield

Applications for biosimilar medicines are continuing to arrive at the European Medicines Agency, with Sandoz’s versions of AbbVie’s Humira and Janssen’s Remicade having just been accepted for filing. This brings to 13 the number of biosimilars under evaluation; seven more are awaiting a marketing authorization decision from the European Commission.

Jizo deities in Kamakura
The number of biosimilar medicinal products is growing in the EU.

More from Approvals

More from Product Reviews